Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB – Get Free Report) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.14. Hemispherx BioPharma shares last traded at $0.13, with a volume of 1,462,716 shares changing hands.
Hemispherx BioPharma Trading Down 3.3 %
The stock’s fifty day moving average price is $0.18.
Hemispherx BioPharma Company Profile
Hemispherx Biopharma, Inc, a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).
Featured Articles
- Five stocks we like better than Hemispherx BioPharma
- Want to Profit on the Downtrend? Downtrends, Explained.
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Growth Stocks: What They Are, Examples and How to Invest
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Are Some of the Best Large-Cap Stocks to Buy?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Hemispherx BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemispherx BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
